---
title: "IMEIK: Subsidiary obtains Minoxidil topical solution \"Drug Registration Certificate\""
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259337244.md"
description: "IMEIK's wholly-owned subsidiary, Beijing Nuobote Biotechnology Co., Ltd., recently obtained the \"Drug Registration Certificate\" for Minoxidil topical solution approved by the National Medical Products Administration. This medication is available in two specifications: 2% and 5%, primarily used for the treatment of androgenetic alopecia and alopecia areata. Minoxidil is a peripheral vasodilator that can stimulate hair growth with long-term use"
datetime: "2025-09-29T12:15:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259337244.md)
  - [en](https://longbridge.com/en/news/259337244.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259337244.md)
---

# IMEIK: Subsidiary obtains Minoxidil topical solution "Drug Registration Certificate"

According to the Zhitong Finance APP, IMEIK (300896.SZ) announced that its wholly-owned subsidiary Beijing Nuobote Biotechnology Co., Ltd. ("Nuobote") has received the drug registration certificates approved and issued by the National Medical Products Administration for minoxidil lotion with specifications of 2% and 5%.

It is reported that minoxidil lotion is a non-prescription dermatological medication. The 2% specification is used for the treatment of male pattern hair loss and alopecia areata; the 5% specification is limited to male use for the treatment of male pattern hair loss and alopecia areata. Minoxidil is a peripheral vasodilator that, when used topically over a long period, can stimulate hair growth in patients with male pattern hair loss and alopecia areata

### Related Stocks

- [300896.CN](https://longbridge.com/en/quote/300896.CN.md)

## Related News & Research

- [Chuck Schumer Says 'Trump Is Making Americans Less Safe,' Links Iran War to Cyberattacks on US Water Systems](https://longbridge.com/en/news/294600389.md)
- [EU naval force says Italian frigate escorts merchant vessel safely through Red Sea](https://longbridge.com/en/news/294574328.md)
- [BioMerieux publishes transcript of H1 2026 results call](https://longbridge.com/en/news/294229000.md)
- [GL Events completes acquisition of medical congress organizer MCO Congrès](https://longbridge.com/en/news/294180353.md)
- [Intermarine begins hull lamination for Italian Navy’s second new-generation minehunter](https://longbridge.com/en/news/294324821.md)